[Treat-all: challenges of partial response and low-level viremia].

Liu, Z H; Hao, X; Hou, J L

Liu, Z H; Hao, X; Hou, J L.

Afiliação

Liu ZH; Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Institutes of Liver Diseases Research of Guangdong Province, Guangzhou 510515, China.
Hao X; Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Institutes of Liver Diseases Research of Guangdong Province, Guangzhou 510515, China.
Hou JL; Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Institutes of Liver Diseases Research of Guangdong Province, Guangzhou 510515, China.

Zhonghua Gan Zang Bing Za Zhi ; 31(3): 242-246, 2023 Mar 20.

Article em Zh | MEDLINE | ID: mdl-37137848

Assuntos

Carcinoma Hepatocelular; Hepatite B Crônica; Neoplasias Hepáticas; Humanos; Antígenos de Superfície da Hepatite B; Viremia; DNA Viral; Vírus da Hepatite B/genética; Hepatite B Crônica/tratamento farmacológico; Antígenos E da Hepatite B

Palavras-chave

Chronic hepatitis B; Low-level viremia; Partial response; Treat-all strategy; Treatment indications

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Neoplasias Hepáticas Tipo de estudo: Guideline Limite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google